Status:
RECRUITING
The Impact of the Hypnosis on the Loss of Weight at Patients in Failure of Bariatric Surgery
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Obesity
Bariatric Surgery
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The therapeutic problem of obesity is weight control, a major difficulty, involving a significant change in eating behavior. A number of studies show that there are many factors of resistance to weigh...
Detailed Description
he therapeutic problem of obesity is weight control, a major difficulty, involving a significant change in eating behavior. A number of studies show that there are many factors of resistance to weight...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Obese patient (BMI = 30 kg / m ²)
- 18 - 65 years ( inclusive borders)
- Patient in failure of bariatric surgery and in which no surgical resumption can be proposed (in view of Reinhold's classification, the failure will be considered as a loss of overweight lower than 50 % in two years further to a bariatric surgery).
- Informed consent
- Patient in measure to realize all the visits and to follow the procedures of the study - Subject affiliated to a social security system
- Exclusion criteria:
- Pregnancy current or planned during the duration of the study, pregnant or breast-feeding women
- Craniopharyngioma or any other evolutionary malignant pathology, or chronic illness in decompensation phase
- Strong probability of not compliance to the protocol or drop-out
- Psychiatric pathology of dissociated type (schizophrenia; psychosis, bipolarity …)
- Sensory (hearing, visual) or cognitive deficits susceptible to hinder the progress of the sessions.
- Incapacity to understand the nature and the purpose of the study and\\or communication difficulties with the investigator
- Patient having already benefited from a coverage by hypnotherapy for loss of weight
- Taken by treatment having an impact on the loss of weight (corticoid, antithyroid …)
- Major protected by the law or considered vulnerable (under guardianship)
Exclusion
Key Trial Info
Start Date :
March 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03485469
Start Date
March 29 2019
End Date
October 1 2026
Last Update
January 17 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
CHR Saint Pierre - maladies métaboliques
La Réunion, France
2
Cécile GODEL
Montpellier, France
3
Orléans University Hospital
Orléans, France
4
Reims University Hospital
Reims, France